These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 24400836)

  • 21. Membrane interactions and conformational preferences of human and avian prion N-terminal tandem repeats: the role of copper(II) ions, pH, and membrane mimicking environments.
    Di Natale G; Pappalardo G; Milardi D; Sciacca MF; Attanasio F; La Mendola D; Rizzarelli E
    J Phys Chem B; 2010 Nov; 114(43):13830-8. PubMed ID: 20936829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. beta-sheet constitution of prion proteins.
    Ji HF; Zhang HY
    Trends Biochem Sci; 2010 Mar; 35(3):129-34. PubMed ID: 20060302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spontaneous beta-helical fold in prion protein: the case of PrP(82-146).
    Saracino GA; Villa A; Moro G; Cosentino U; Salmona M
    Proteins; 2009 Jun; 75(4):964-76. PubMed ID: 19089953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Introduction of glutamines into the B2-H2 loop promotes prion protein conversion.
    Avbelj M; Hafner-Bratkovič I; Jerala R
    Biochem Biophys Res Commun; 2011 Oct; 413(4):521-6. PubMed ID: 21910969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extremely rapid folding of the C-terminal domain of the prion protein without kinetic intermediates.
    Wildegger G; Liemann S; Glockshuber R
    Nat Struct Biol; 1999 Jun; 6(6):550-3. PubMed ID: 10360358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular architecture of human prion protein amyloid: a parallel, in-register beta-structure.
    Cobb NJ; Sönnichsen FD; McHaourab H; Surewicz WK
    Proc Natl Acad Sci U S A; 2007 Nov; 104(48):18946-51. PubMed ID: 18025469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prion protein NMR structure from tammar wallaby (Macropus eugenii) shows that the beta2-alpha2 loop is modulated by long-range sequence effects.
    Christen B; Hornemann S; Damberger FF; Wüthrich K
    J Mol Biol; 2009 Jun; 389(5):833-45. PubMed ID: 19393664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction of the 106-126 prion peptide with lipid membranes and potential implication for neurotoxicity.
    Dupiereux I; Zorzi W; Lins L; Brasseur R; Colson P; Heinen E; Elmoualij B
    Biochem Biophys Res Commun; 2005 Jun; 331(4):894-901. PubMed ID: 15882962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutation-Dependent Refolding of Prion Protein Unveils Amyloidogenic-Related Structural Ramifications: Insights from Molecular Dynamics Simulations.
    Palaniappan C; Narayanan RC; Sekar K
    ACS Chem Neurosci; 2021 Aug; 12(15):2810-2819. PubMed ID: 34296847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. β-sheet-like formation during the mechanical unfolding of prion protein.
    Tao W; Yoon G; Cao P; Eom K; Park HS
    J Chem Phys; 2015 Sep; 143(12):125101. PubMed ID: 26429042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Post-translational hydroxylation at the N-terminus of the prion protein reveals presence of PPII structure in vivo.
    Gill AC; Ritchie MA; Hunt LG; Steane SE; Davies KG; Bocking SP; Rhie AG; Bennett AD; Hope J
    EMBO J; 2000 Oct; 19(20):5324-31. PubMed ID: 11032800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of the N-terminal domain on the aggregation properties of the prion protein.
    Frankenfield KN; Powers ET; Kelly JW
    Protein Sci; 2005 Aug; 14(8):2154-66. PubMed ID: 16046631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A scrapie-like unfolding intermediate of the prion protein domain PrP(121-231) induced by acidic pH.
    Hornemann S; Glockshuber R
    Proc Natl Acad Sci U S A; 1998 May; 95(11):6010-4. PubMed ID: 9600908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electron paramagnetic resonance evidence for binding of Cu(2+) to the C-terminal domain of the murine prion protein.
    Cereghetti GM; Schweiger A; Glockshuber R; Van Doorslaer S
    Biophys J; 2001 Jul; 81(1):516-25. PubMed ID: 11423433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prion protein mPrP[F175A](121-231): structure and stability in solution.
    Christen B; Hornemann S; Damberger FF; Wüthrich K
    J Mol Biol; 2012 Nov; 423(4):496-502. PubMed ID: 22922482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Horse prion protein NMR structure and comparisons with related variants of the mouse prion protein.
    Pérez DR; Damberger FF; Wüthrich K
    J Mol Biol; 2010 Jul; 400(2):121-8. PubMed ID: 20460128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinct morphological and electrophysiological properties of an elk prion peptide.
    Glaves JP; Gorski PA; Alier K; Ma L; Renault L; Primeau JO; Jhamandas JH; Young HS
    Peptides; 2013 Feb; 40():49-56. PubMed ID: 23262353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental approaches to the interaction of the prion protein with nucleic acids and glycosaminoglycans: Modulators of the pathogenic conversion.
    Silva JL; Vieira TC; Gomes MP; Rangel LP; Scapin SM; Cordeiro Y
    Methods; 2011 Mar; 53(3):306-17. PubMed ID: 21145399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinetic intermediate in the folding of human prion protein.
    Apetri AC; Surewicz WK
    J Biol Chem; 2002 Nov; 277(47):44589-92. PubMed ID: 12356762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective processing and metabolism of disease-causing mutant prion proteins.
    Ashok A; Hegde RS
    PLoS Pathog; 2009 Jun; 5(6):e1000479. PubMed ID: 19543376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.